[Alpha interferon treatment in hairy cell leukemia].
Since 1984 alpha-interferon (alpha IFN) has been the treatment of choice in cases of hairy-cell leukaemia. However, eight years' experience shows that, although a large majority of the patients are improved, they are not cured. Thus, a new type of cytostatic drug, perhaps capable of cure as well, may replace alpha-IFN for the treatment of hairy-cell leukaemia in the future.
Hagberg
H
H
Kliniken för allmän onkologi, Akademiska Sjukhuset, Uppsala.
D015762:2-Chloroadenosine / Q000008:administration & dosage / Q000031:analogs & derivatives; D017338:Cladribine; D003839:Deoxyadenosines / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy / Q000628:therapy*; D015649:Pentostatin / Q000008:administration & dosage
D003839:Deoxyadenosines; D016898:Interferon-alpha; D015762:2-Chloroadenosine; D015649:Pentostatin; D017338:Cladribine
Alfa-interferonbehandling vid hårcellsleukemi.